CRVO Kronos AI forecast
A 30-trading-day price forecast for CervoMed Inc. (CRVO) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts CervoMed Inc. at $2.77 on 2026-12-08, +24.8% from the last close of $2.22 on 2026-10-27. Eight out of ten sampled paths end between $2.66 and $2.86, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of CRVO
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $2.35 | $2.28 | $2.41 |
| 2026-11-10 | $2.45 | $2.30 | $2.60 |
| 2026-11-17 | $2.48 | $2.36 | $2.62 |
| 2026-11-24 | $2.54 | $2.37 | $2.67 |
| 2026-12-01 | $2.70 | $2.50 | $2.85 |
| 2026-12-08 | $2.77 | $2.66 | $2.86 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for CRVO?
- Kronos AI's median forecast for CRVO is $2.77 in 30 trading days, +24.8% from the last close, with a 10–90% range of $2.66 to $2.86.
- Is the CRVO Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC